Team:BIOSINT Mexico/risks

From 2012e.igem.org

(Difference between revisions)
 
Line 130: Line 130:
                                 <p class="clr-1"><strong>Risk assumptions.</strong></p>
                                 <p class="clr-1"><strong>Risk assumptions.</strong></p>
                             </div>
                             </div>
-
                             <p>Within the genomic services, Kuxtal group may encounter several issues such as:
+
                             <p>Within the genomic services, Kuxtal group may encounter several issues such as:</br></br>
-
·      Problems with costume agencies and suppliers that may find some problems related to delayed, broken or missing deliveries of reagents. Kuxtal group plans to overcome these issues by establishing a strong viable business network in which custom agents and suppliers that haste this process.</br></br>
+
·      Problems with costume agencies and suppliers that may find some problems related to delayed, broken or missing deliveries of reagents. Kuxtal group plans to overcome these issues by establishing a strong viable business network in which custom agents and suppliers help quickening this process.</br></br>
   
   
·      The equipment could present some technical or operational failures in the synthesizer or in the sequencer, this is why Kuxtal employees will be trained to give maintenance to the equipment and identify problems in the production chain.</br></br>
·      The equipment could present some technical or operational failures in the synthesizer or in the sequencer, this is why Kuxtal employees will be trained to give maintenance to the equipment and identify problems in the production chain.</br></br>
   
   
-
·      The potential risk that another biotechnology company sets a market goal on México. This scenario is possible in the medium or long term, due to the current economic stability that the country has, and its strategic position and leadership in Latin-America. For Kuxtal will compete in quality and customer service terms such as delivery time and personalized customer support, services that even grand companies aren’t able to provide.</br></br>
+
·      The potential risk of another biotechnology company setting a market goal on México. This scenario is possible in the medium or long term, due to the current economic stability that the country has, and its strategic position and leadership in Latin-America. For Kuxtal will compete in quality and customer service terms such as delivery time and personalized customer support, services that even grand companies aren’t able to provide.</br></br>
   
   
-
·      There are potential customers, which are federally funded research institutes, which may not require Kuxtal’s services and/or products as often as predicted. As a response to this scenario, the marketing department will be to establish a wide customer directory, which will be equally formed by private and public institutions. Also Kuxtal group will capitalize the relationship with state's government; this will allow this group to be part of the Biotechnology business cluster that is currently developing in Querétaro.</p>
+
·      There are potential customers, which are federally funded research institutes, which may not require Kuxtal’s services and/or products as often as predicted. As a response to this scenario, the marketing department will be to establish a wide customer directory, which will be equally formed by private and public institutions. Also Kuxtal group will capitalize the relationship with the state's government; this will allow this group to be a part of the Biotechnology business cluster that is currently developing in Querétaro.</p>
                         </div>
                         </div>
               </div>
               </div>

Latest revision as of 01:48, 28 October 2012

Kuxtal

WHAT I CANNOT CREATE, I DO NOT UNDERSTAND RICHARD FEYNMAN’S
The Pyramid of el Pueblito, is located at 6 km from Querétaro City, it was built by the Chupícuaro culture 300 years BC.
The same year Euclid publishes a 13 volume work called Elements.

Risk Analysis

Risk assumptions.

Within the genomic services, Kuxtal group may encounter several issues such as:

· Problems with costume agencies and suppliers that may find some problems related to delayed, broken or missing deliveries of reagents. Kuxtal group plans to overcome these issues by establishing a strong viable business network in which custom agents and suppliers help quickening this process.

· The equipment could present some technical or operational failures in the synthesizer or in the sequencer, this is why Kuxtal employees will be trained to give maintenance to the equipment and identify problems in the production chain.

· The potential risk of another biotechnology company setting a market goal on México. This scenario is possible in the medium or long term, due to the current economic stability that the country has, and its strategic position and leadership in Latin-America. For Kuxtal will compete in quality and customer service terms such as delivery time and personalized customer support, services that even grand companies aren’t able to provide.

· There are potential customers, which are federally funded research institutes, which may not require Kuxtal’s services and/or products as often as predicted. As a response to this scenario, the marketing department will be to establish a wide customer directory, which will be equally formed by private and public institutions. Also Kuxtal group will capitalize the relationship with the state's government; this will allow this group to be a part of the Biotechnology business cluster that is currently developing in Querétaro.